Researchers at The Johns Hopkins University School of Medicine have identified a long noncoding RNA that is upregulated by nerve injury associated with neuropathic pain. The molecule silences voltage-gated potassium channel Kv1.2 exclusively in damaged neurons and could thus be a new target for the indication.